Alizé Pharma Overview
- Year Founded
-
2007
- Status
-
Acquired/Merged
- Employees
-
6
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$74.6M
Alizé Pharma General Information
Description
Developer of biopharmaceutical drugs, proteins and peptides. The company's biopharmaceutical drugs, proteins and peptides identifies unacylated ghrelin, a gastrointestinal peptide hormone, as a new therapeutic class, providing therapeutic products for the treatment of diabetes, cancer and metabolic diseases.
Contact Information
Corporate Office
- 15, Chemin du Saquin
- Espace Europeen, Building G
- 69130 Ecully
- France
Corporate Office
- 15, Chemin du Saquin
- Espace Europeen, Building G
- 69130 Ecully
- France
Alizé Pharma Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Merger/Acquisition | 20-Dec-2017 | $74.6M | Completed | Generating Revenue | ||
| 5. Later Stage VC | 17-Mar-2015 | Completed | Generating Revenue | |||
| 4. Later Stage VC | 10-Sep-2014 | Completed | Generating Revenue | |||
| 3. Later Stage VC | 04-Jun-2012 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series B) | 01-Sep-2009 | $4.28M | $5.68M | Completed | Generating Revenue | |
| 1. Early Stage VC | 01-Sep-2007 | $1.41M | $1.41M | Completed | Generating Revenue |
Alizé Pharma Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| ABSA P2 | ||||||||
| ABSA P1 | ||||||||
| ABSA 2012-04 | ||||||||
| ABSA 2009-01 | 13,433 | $1.317082 | $88.24 | $88.24 | 1x | $88.24 | 8.61% | |
| Ordinary | 15,235 | $1.317082 | $60.51 | $60.51 | 1x | $60.51 | 9.77% |
Alizé Pharma Comparisons
Industry
Financing
Details
Alizé Pharma Competitors (27)
One of Alizé Pharma’s 27 competitors is Dicerna Pharmaceuticals, a Formerly VC-backed company based in Lexington, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Dicerna Pharmaceuticals | Formerly VC-backed | Lexington, MA | ||||
| Alnylam Pharmaceuticals | Formerly VC-backed | Cambridge, MA | ||||
| Intas Pharmaceuticals | Private Equity-Backed | Ahmedabad, India | ||||
| Gilead | Formerly VC-backed | Foster City, CA | ||||
| Arrowhead Pharmaceuticals | Corporation | Pasadena, CA |
Alizé Pharma Signals
Alizé Pharma Former Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Bpifrance | Sovereign Wealth Fund | Minority | ||
| CEMA | Corporation | Minority | ||
| Credit Agricole | Investment Bank | Minority | ||
| Kreaxi | Venture Capital | Minority | ||
| Octalfa | Venture Capital | Minority |
Alizé Pharma FAQs
-
When was Alizé Pharma founded?
Alizé Pharma was founded in 2007.
-
Where is Alizé Pharma headquartered?
Alizé Pharma is headquartered in Ecully, France.
-
What is the size of Alizé Pharma?
Alizé Pharma has 6 total employees.
-
What industry is Alizé Pharma in?
Alizé Pharma’s primary industry is Pharmaceuticals.
-
Is Alizé Pharma a private or public company?
Alizé Pharma is a Private company.
-
What is the current valuation of Alizé Pharma?
The current valuation of Alizé Pharma is .
-
What is Alizé Pharma’s current revenue?
The current revenue for Alizé Pharma is .
-
How much funding has Alizé Pharma raised over time?
Alizé Pharma has raised $18.4M.
-
Who are Alizé Pharma’s investors?
Bpifrance, CEMA, Credit Agricole, Kreaxi, and Octalfa are 5 of 9 investors who have invested in Alizé Pharma.
-
Who are Alizé Pharma’s competitors?
Dicerna Pharmaceuticals, Alnylam Pharmaceuticals, Intas Pharmaceuticals, Gilead, and Arrowhead Pharmaceuticals are some of the 27 competitors of Alizé Pharma.
-
When was Alizé Pharma acquired?
Alizé Pharma was acquired on 20-Dec-2017.
-
Who acquired Alizé Pharma?
Alizé Pharma was acquired by Millendo Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process